PAR 29.3% 26.5¢ paradigm biopharmaceuticals limited..

"Mr Polizzi successfully led the process for several dozen U.S....

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 200 Posts.
    lightbulb Created with Sketch. 383

    "Mr Polizzi successfully led the process for several dozen U.S. and International Pharma strategic license and acquisitions, from identification of target companies, negotiations, and due diligence through execution. Evaluated hundreds of prospective M&A, licensing, or acquisition transactions throughout his career."

    This is what is immediately relevant for us now. Evaluating hundreds, and proceeding with dozens, of licenses or acquisitions, is a lot. He will know his counterparts in the other majors, what they are looking for, the basis for their assessments, what they will need to complete a deal, and the outer limits of their negotiating positions.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.5¢
Change
0.060(29.3%)
Mkt cap ! $85.80M
Open High Low Value Volume
21.0¢ 26.5¢ 21.0¢ $861.3K 3.574M

Buyers (Bids)

No. Vol. Price($)
1 194 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 55325 1
View Market Depth
Last trade - 15.59pm 17/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.